Private Advisor Group LLC Acquires 2,278 Shares of Axon Enterprise, Inc $AXON

Private Advisor Group LLC raised its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 20.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 13,326 shares of the biotechnology company’s stock after buying an additional 2,278 shares during the period. Private Advisor Group LLC’s holdings in Axon Enterprise were worth $9,563,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. Stone House Investment Management LLC bought a new stake in shares of Axon Enterprise during the third quarter worth about $29,000. New Millennium Group LLC acquired a new stake in shares of Axon Enterprise in the 3rd quarter worth about $29,000. Darwin Wealth Management LLC bought a new position in Axon Enterprise in the 2nd quarter valued at about $37,000. Root Financial Partners LLC bought a new position in Axon Enterprise in the 3rd quarter valued at about $34,000. Finally, Elevation Point Wealth Partners LLC acquired a new position in Axon Enterprise during the 2nd quarter valued at about $56,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, CAO Jennifer H. Mak sold 1,500 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $573.45, for a total transaction of $860,175.00. Following the completion of the sale, the chief accounting officer directly owned 12,240 shares of the company’s stock, valued at $7,019,028. This trade represents a 10.92% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction on Wednesday, February 25th. The stock was sold at an average price of $500.24, for a total value of $5,002,400.00. Following the sale, the chief executive officer owned 3,090,997 shares in the company, valued at $1,546,240,339.28. The trade was a 0.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 24,634 shares of company stock worth $13,803,095. 4.40% of the stock is owned by company insiders.

Key Stories Impacting Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Recent operating momentum and scale: company commentary and filings highlighted robust device and software demand, rising ARR/bookings and accelerating revenue that underpinned the prior rally. Axon slips as investors digest rich valuation after a sharp post-earnings run-up
• Positive Sentiment: Analyst backing and price-target runway: multiple firms maintain buy/overweight ratings and the median 6‑month target sits well above current levels, giving upside for longer-term holders. Axon slips as investors digest rich valuation after a sharp post-earnings run-up
• Positive Sentiment: Momentum recap: AXON had climbed nearly 29% over the prior month on strong device/software demand — a factor that supports the bull case if execution continues. Axon Stock Rises 28.6% in a Month: Should Investors Buy or Wait?
• Neutral Sentiment: No meaningful short-interest signal (data shows zero or NaN) — likely a reporting anomaly, so it shouldn’t be interpreted as a fresh bearish catalyst.
• Neutral Sentiment: Third‑party/industry headlines referencing “Axon” (e.g., AppLovin’s “Axon by AppLovin” product and related studies) are unrelated to Axon Enterprise’s business and can confuse coverage — treat those items as industry noise. AppLovin (APP) Is Up 19.5% After Showcasing AXON 2.0 And AI E-commerce Pivot
• Negative Sentiment: Profit‑taking and valuation sensitivity: analysts and market commentary point to a classic post‑earnings retracement after a fast run; high valuation metrics make the stock susceptible to short‑term pullbacks. Axon slips as investors digest rich valuation after a sharp post-earnings run-up
• Negative Sentiment: Heavy insider selling noted in recent disclosures increases near‑term perceived risk and can sap sentiment even if proceeds are routine. Axon slips as investors digest rich valuation after a sharp post-earnings run-up
• Negative Sentiment: Relative underperformance vs. peers on the day added selling pressure, suggesting short‑term rotation rather than a fresh fundamental shift. Axon Enterprise Inc. stock underperforms Tuesday when compared to competitors

Axon Enterprise Trading Down 2.3%

NASDAQ:AXON opened at $517.57 on Thursday. Axon Enterprise, Inc has a 52 week low of $396.41 and a 52 week high of $885.91. The firm has a 50-day moving average price of $533.80 and a two-hundred day moving average price of $613.08. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.29 and a current ratio of 2.53. The firm has a market cap of $41.61 billion, a price-to-earnings ratio of 340.51, a price-to-earnings-growth ratio of 11.31 and a beta of 1.46.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share for the quarter, topping analysts’ consensus estimates of $1.60 by $0.55. The firm had revenue of $796.72 million for the quarter, compared to the consensus estimate of $755.29 million. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.The company’s revenue was up 38.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.08 EPS. On average, equities analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have commented on AXON. UBS Group decreased their price objective on Axon Enterprise from $610.00 to $570.00 and set a “neutral” rating for the company in a report on Wednesday, February 25th. Robert W. Baird set a $800.00 target price on Axon Enterprise in a report on Wednesday, February 25th. Craig Hallum reaffirmed a “buy” rating and set a $820.00 target price on shares of Axon Enterprise in a research report on Wednesday, February 25th. Needham & Company LLC decreased their price target on Axon Enterprise from $870.00 to $600.00 and set a “buy” rating for the company in a report on Friday, February 20th. Finally, Citigroup reissued a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, February 25th. Sixteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and an average price target of $762.93.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.